cobas t 511 coagulation analyzer and cobas t 711 coagulation analyzer

Making innovation your routine

cobas t 511 & cobas t 711 coagulation analyzers

We answer your need for maximized workflow efficiency and reliable results

Empowering you to support the best outcome for your patients.

For you. For the patient. For tomorrow.

Today's coagulation lab needs to meet clinicians' demand for fast and accurate results and cost effective solutions for a large number of routine coagulation parameters.

The standalone mid-throughput cobas t 511 coagulation analyzer and the high-throughput cobas t 711 coagulation analyzer aid in the diagnosis of coagulation abnormalities and in monitoring anticoagulant therapy.

By delivering high processing power, seamless workflow dynamics, and unique walk away reagent management (W.A.R.M.) with smart sample handling, we answer your need for maximized workflow efficiency and reliable results. Empowering you to support the best outcome for your patients.

High Processing Power

With their high processing power and extensive menu, the cobas t coagulation analyzers enable laboratories to complete their daily testing workload fast.

Key features

High throughput
Large on-board sample capacity
High on-board reagent capacity and up to 2 weeks of on-board stability
Increased on-board testing of up to 34,200 tests that allows loading of reagents only once per 2 weeks (for an XL workload Coag Lab)
Flexible sample loading options and connection to automation
Analyzers can be used in random-access or batch modes, and offer true STAT capabilities with dedicated slots for urgent samples

Seamless Workflow
Dynamics

The cobas t coagulation analyzers offer ease of use, continuous operation and maximized productivity, while ensuring operator safety and reliable results to help support better patient care. These benefits are enabled through:

Continuous loading/unloading of samples, reagents, consumables and waste
Flexible sample tube handling supported
- Open and closed sample tubes on the same rack
- Multiple tube vendors
Sample integrity checks and full traceability of results
e-Services available include: e-library access to download key information, Laboratory Information Systems connectivity and remote service support functionalities

Unique Walk Away Reagent
Management (W.A.R.M.)

The cobas t coagulation analyzers are capable of fully automated and scheduled reagent reconstitution - the ultimate enabler of continuous operation. This innovative and convenient concept minimizes risks of user error, and ensures the optimized use and high quality of reagents.

Reagent cassette concept minimizes risk of contamination and evaporation
Automated scheduled reagent reconstitution and equilibration to room temperature when needed, without operator intervention
Automated import of electronic data via barcode technology

Making innovation your routine

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

The perfect fit for your testing needs

The cobas t 511 and the cobas t 711 coagulation analyzer give your lab the freedom to choose the perfect fit for your testing needs.

Compare

Available Assays

Different throughput needs.

Same standard of quality and innovation.

The right fit for every workload.

Because one size does not fit all, Roche offers two different options to benefit from the innovation brought to coagulation testing: the mid-throughput cobas t 511 coagulation analyzer, and the high-throughput cobas t 711 coagulation analyzer.

cobas t 511
coagulation analyzer

Throughput of 195 tests/hr
Sample capacity of 75
57 reagent cassette positions for up to 34,200 tests on board
Sample integrity check: HIL index, Clog detection, Automatic cuvette checks
Sample loading and unloading is automated via front loading port

cobas t 711
coagulation analyzer

Throughput of 390 tests/hr
Sample capacity of 225
57 reagent cassette positions for up to 34,200 tests on board
Sample integrity check: HIL index, Clog detection, Automatic cuvette checks
Sample loading and unloading is automated via the front loading port and via the side balcony
Connectivity to automation with the cobas^® 8100 automated workflow series and the cobas^® connection modules
Laboratory automation

Available assays and tests

Antithrombin

In vitro assay for the quantitative determination of antithrombin activity in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of antithrombin deficiency.

Anti-Xa

In vitro assay for the quantitative determination of the anti-Xa activity of unfractionated (UFH) and low molecular weight (LMWH) heparins in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the management of anti-Xa Heparin therapy.

APC Resistance

APC Resistance is a functional assay for the determination of resistance of factor Va to inactivation by activated protein C (APC) caused by the factor V Leiden mutation (FV:R506Q) in citrated plasma on indicated cobas t analyzers.

aPTT

In vitro assay, with reduced lupus sensitivity, for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

aPTT Lupus

In vitro assay, with increased lupus sensitivity, for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

aPTT Screen

In vitro assay for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

D-Dimer

In vitro assay for the quantitative immunological determination of fibrin degradation products (D‑dimer and X‑oligomers) in human citrated plasma on the indicated cobas t analyzers. In conjunction with a non-high clinical probability assessment, a normal D‑dimer result (< 0.5 μg FEUa)/mL) is intended as an aid in the exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Fibrinogen

In vitro assay for the quantitative determination of fibrinogen (Clauss method) in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the detection of hypo- and hyperfibrinogenemia, dysfibrinogenemia and afibrinogenemia.

FII

Human plasma immunodepleted of Factor II for the quantitative determination of Factor II activity in citrated plasma, based on the prothrombin time (PT) assay, on the indicated cobas t analyzers.

Free Protein S

In vitro assay for the quantitative determination of free protein S in human citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of inherited and acquired protein S deficiency.

Human plasma immunodepleted of Factor V for the quantitative determination of Factor V activity in citrated plasma, based on the prothrombin time (PT) assay, on the indicated cobas t analyzers.Human plasma immunodepleted of Factor II for the quantitative determination of Factor II activity in citrated plasma, based on the prothrombin time (PT) assay, on the indicated cobas t analyzers.

FVII

Human plasma immunodepleted of Factor VII for the quantitative determination of Factor VII activity in citrated plasma, based on the prothrombin time (PT) assay, on the indicated cobas t analyzers.

FVIII

Human plasma immunodepleted of Factor VIII for the quantitative determination of Factor VIII activity in citrated plasma, based on the activated partial thromboplastin time (aPTT) assay, on the indicated cobas t analyzers.

Human plasma immunodepleted of Factor X for the quantitative determination of Factor X activity in citrated plasma, based on the prothrombin time (PT) assay, on the indicated cobas t analyzers.

HIL Test

In vitro test for the semi-quantitative determination of the lipemia index, hemolysis index and icterus index in citrated plasma on cobas t systems.

Lupus S, Lupus C

In vitro assays to screen for (Lupus S) and to confirm (Lupus C) the presence of lupus anticoagulants in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of anti‑phospholipid syndrome.

PT derived Fibrinogen

The derived fibrinogen result is intended as an aid in the diagnosis of a fibrinogen deficiency.

Protein C Chromogenic

In vitro chromogenic assay for the quantitative determination of Protein C activity in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of inherited and acquired Protein C deficiencies.

PT Owren

In vitro assay for the determination of the Owrens prothrombin time in citrated plasma on the indicated cobas t analyzers. The Owrens prothrombin time is intended as an aid in the management of vitamin K antagonist therapy.

PT Rec

In vitro assay for the determination of prothrombin time and derived fibrinogen in citrated plasma on the indicated cobas t analyzers. The prothrombin time is used for evaluation of the extrinsic coagulation pathway and as an aid in the management of vitamin K antagonist therapy. The derived fibrinogen result is intended as an aid in the diagnosis of a fibrinogen deficiency.

Thrombin Time

In vitro assay for the determination of Thrombin Time (TT) in human citrated plasma on the indicated cobas t analyzers.s.

vWF Act

In vitro assay for the quantitative determination of platelet glycoprotein Ib binding activity of von Willebrand factor in human citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of inherited and acquired von Willebrand Disease (vWD).

Information taken from respective method sheets